CardioExchange Archive

January 29th, 2014

What’s the Best Blood Transfusion Protocol for Anemic ACS Patients?

Sunil Rao, MD

Sunil V. Rao discusses his editorial about TRANSFUSION-2, a study of the platelet and inflammatory effects of blood transfusions in ACS and non-ACS patients with anemia.

---

May 28th, 2013

Selections from Richard Lehman’s Literature Review: May 28th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the mechanisms of acute coronary syndromes, the gap in life expectancy from preventable physical illness (including CVD) in psychiatric patients, and a comparison study of CABG vs. PCI.

---

October 8th, 2012

Selections from Richard Lehman’s Literature Review: October 8th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include beta-blockers and the lack of a cardioprotective effect for certain patients; intra-aortic balloon support for MI with cardiogenic shock; prasugrel vs. clopidogrel for acute coronary syndromes without revascularization; CRP, fibrinogen, and CVD prediction; and a comparison of thrombectomy devices for acute ischemic stroke.

---

August 26th, 2012

TRILOGY at ESC: No Advantage for Prasugrel Over Clopidogrel in Medical ACS Patients

Larry Husten, PHD

The newer antiplatelet agent prasugrel was no better than the old standby clopidogrel for treating patients with acute coronary syndrome (ACS) who are not undergoing revascularization. The results of the TRILOGY ACS (Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes) trial were presented by Matt Roe at the European Society of […]

---

May 11th, 2012

A ‘Brilinta’ Theory on Why Ticagrelor Doesn’t Work as Well in the U.S.

Harry Peled, md

Harry Peled wonders whether intermediate-dose aspirin may simply be so effective that it obviates the need for a P2Y12-receptor antagonist.

---